Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 691-694, April 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barranco, S. C.
Right arrow Articles by Humphrey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barranco, S. C.
Right arrow Articles by Humphrey, R. M.

Response of Mammalian Cells following Treatment with Bleomycin and 1,3-Bis(2-chloroethyl)-1-nitrosourea during Plateau Phase1

S. C. Barranco, Judy K. Novak and Ronald M. Humphrey

Departments of Surgery [S. C. B., J. K. N.] and Physics, [R. M. H.], The University of Texas at Houston M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77025

One hr of exposure to bleomycin (100 µg/ml) during the plateau phase caused a 10-fold greater decrease in the survival fraction of Chinese hamster ovary cells than was caused by bleomycin treatment during the exponential growth period. One hr of exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea (25 µg/ml) had no effect on the survival fraction of cells treated in the exponential growth period; however, the same dose reduced the survival fraction of cells treated in plateau phase to 0.0002 (this represents a 500-fold decrease in the survival fraction).

1 This work was supported by American Cancer Society Institutional Research Grant ACS-IN-43-L.

Received 9/ 8/72. Accepted 12/28/72.




This article has been cited by other articles:


Home page
RadiologyHome page
K. Kishi, M. Matsunaka, M. Sato, T. Sonomura, M. Sakurane, and K. Uede
T1 and T2 Lip Cancer: A Superselective Method of Facial Arterial Infusion Therapy-Preliminary Experience
Radiology, October 1, 1999; 213(1): 173 - 179.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.